Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human MAP3K10 Stable Cell Line

    [CAT#: S01YF-1023-PY6]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1223 Magic™ Human MLK2(MAP3K10) in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;BxPC-3;PANC-1
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cardiovascular Research
    Related Diseases
    Cardiofaciocutaneous Syndrome 1
    Gene ID
    Human:4294
    UniProt ID
    Human:Q02779

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    MAP3K10 has been implicated in various biological processes and diseases. In the field of hypertension and COVID-19, MAP3K10 was identified as one of the top-ranking concepts related to resistant hypertension and COVID-19. In murine cytomegalovirus-induced hearing loss, MAP3K10 was found to be a host restriction factor against viral infection and an upstream regulator of signaling pathways involved in cell death. In intracranial aneurysm, DNA methylation of the MAP3K10 gene was found to be associated with the development of the condition. In pancreatic cancer, miR-146b-3p was found to regulate the proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10. Additionally, in breast cancer, MAP3K10 was shown to be downregulated by the Hippo tumor suppressor pathway, leading to inhibition of the transcription co-activation and tumor growth mediated by WBP2. Overall, MAP3K10 appears to play a role in various biological processes and diseases, including hypertension, viral infections, aneurysms, and cancer.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human MAP3K10 Stable Cell Line (S01YF-1023-PY6). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Alex Miller (Verified Customer)

    How does MAP3K10 interact with miRNAs in cancer? Jan 25 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Research indicates a reversed nonlinear correlation between MAP3K10 protein levels and miR-146b-3p expression in pancreatic cancer​​​​. Jan 25 2021

    chat Alex Miller (Verified Customer)

    What is the relationship between MAP3K10 and DNA methylation in disease? Jun 12 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    DNA methylation of the MAP3K10 gene may participate in the development of intracranial aneurysm, though the association with MAP3K10 mRNA expression requires further validation​​​​. Jun 12 2023

    Published Data

    Fig.1 MAP3K10 promoted the proliferation of pancreatic cancer cell lines in vitro.

    Enhanced cell proliferation in PANC-1 cells was observed with EdU (5-ethynyl-20-deoxyuridine) assays upon MAP3K10 overexpression, whereas a reduction in cell proliferation of BxPC-3 cells was induced by MAP3K10 knockdown.

    Ref: An, Yong, et al. "MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2." Cancer letters 329.2 (2013): 228-235.

    Pubmed: 23178452

    DOI: 10.1016/j.canlet.2012.11.005

    Research Highlights

    Kartchner, David. et al. "Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19." Biology, 2023.
    Multiple studies have reported new or exacerbated persistent or resistant hypertension in patients previously infected with COVID-19. The authors utilized literature-based discovery to identify and prioritize multi-scalar explanatory biology that relates resistant hypertension to COVID-19. Using SemNet 2.0, they performed cross-domain text mining of over 33 million PubMed articles within a comprehensive knowledge graph. Through unsupervised rank aggregation, they determined the most relevant concepts utilizing the normalized HeteSim score. After conducting a series of simulations, the authors found that concepts directly related to COVID-19 and resistant hypertension, or connected via one of three renin-angiotensin-aldosterone system hub nodes, were the top-ranking factors. These included various genes, hormones, enzymes, and proteins. The identified concepts were mapped to six physiological themes: altered endocrine function, inflammation or cytokine storm, lipid metabolism and atherosclerosis, sympathetic input to blood pressure regulation, altered entry of COVID-19 virus, and unknown.
    Kartchner, David. et al. "Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19." Biology, 2023.
    Pubmed: 37759668   DOI: 10.3390/biology12091269

    Li, Menghua. et al. "Murine cytomegalovirus employs the mixed lineage kinases family to regulate the spiral ganglion neuron cell death and hearing loss." Neuroscience letters, 2023.
    Recent studies have shown that sensorineural hearing loss (SNHL) caused by cytomegalovirus (CMV) is a global epidemic. The degree of spiral ganglion neuron (SGN) loss has been found to be linked to hearing loss following CMV infection. The aim of this study was to gain a better understanding of the mechanisms behind CMV-induced SGN death and to identify potential intervention strategies. The findings revealed that both apoptosis and pyroptosis contribute to CMV-induced SGN death, which is mediated by the activation of the p53/JNK and NLRP3/caspase-1 signaling pathways, respectively. It was also demonstrated that the mixed lineage kinase family (MLK1/2/3), known as host restriction factors against viral infection, also serve as upstream regulators of these signaling pathways. Additionally, the MLKs inhibitor URMC-099 was found to have a protective effect against CMV-induced SGN death and hearing loss. These results suggest that targeting the MLK signaling pathway may be a promising approach for preventing both apoptosis and pyroptosis during CMV infection and for treating hearing loss.
    Li, Menghua. et al. "Murine cytomegalovirus employs the mixed lineage kinases family to regulate the spiral ganglion neuron cell death and hearing loss." Neuroscience letters, 2023.
    Pubmed: 36455693   DOI: 10.1016/j.neulet.2022.136990

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare